▶ 調査レポート

胎児性アルコールスペクトラム障害（FASD）治療の世界市場（～2026年）
• 英文タイトル：Global Fetal Alcohol Spectrum Disorder Treatment Market Size, Status and Forecast 2020-2026

QYResearchが調査・発行した産業分析レポートです。胎児性アルコールスペクトラム障害（FASD）治療の世界市場（～2026年） / Global Fetal Alcohol Spectrum Disorder Treatment Market Size, Status and Forecast 2020-2026 / MRC2-11QY11930資料のイメージです。• レポートコード：MRC2-11QY11930
• 出版社/出版日：QYResearch / 2020年11月25日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、97ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：ヘルスケア
• 販売価格（消費税別）
  Single User￥577,200 (USD3,900)▷ お問い合わせ
  Multi User￥865,800 (USD5,850)▷ お問い合わせ
  Enterprise License￥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
当調査資料は胎児性アルコールスペクトラム障害（FASD）治療のグローバル市場について調査・分析したレポートです。種類別（抗うつ薬、覚醒剤、神経弛緩薬、抗不安薬）市場規模、用途別（病院薬局、小売薬局、ドラッグストア、Eコマース）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別胎児性アルコールスペクトラム障害（FASD）治療の競争状況、市場シェア
・世界の胎児性アルコールスペクトラム障害（FASD）治療市場：種類別市場規模 2015年-2020年（抗うつ薬、覚醒剤、神経弛緩薬、抗不安薬）
・世界の胎児性アルコールスペクトラム障害（FASD）治療市場：種類別市場規模予測 2021年-2026年（抗うつ薬、覚醒剤、神経弛緩薬、抗不安薬）
・世界の胎児性アルコールスペクトラム障害（FASD）治療市場：用途別市場規模 2015年-2020年（病院薬局、小売薬局、ドラッグストア、Eコマース）
・世界の胎児性アルコールスペクトラム障害（FASD）治療市場：用途別市場規模予測 2021年-2026年（病院薬局、小売薬局、ドラッグストア、Eコマース）
・北米の胎児性アルコールスペクトラム障害（FASD）治療市場分析：米国、カナダ
・ヨーロッパの胎児性アルコールスペクトラム障害（FASD）治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの胎児性アルコールスペクトラム障害（FASD）治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の胎児性アルコールスペクトラム障害（FASD）治療市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの胎児性アルコールスペクトラム障害（FASD）治療市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：Forest Laboratories、Wyeth、Amneal Pharms、GlaxoSmithKline、Eli Lilly、Schering-Plough、Pfizer
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Fetal alcohol spectrum disorder are the group of conditions occurring in new born with a wide range of disabilities.
Fetal alcohol spectrum disorder treatment market is an evolving market owing to the gradual change in the lifestyle and increased alcohol consumption by pregnant women, eventually increasing the incidence rate of the disorder.

Market Analysis and Insights: Global Fetal Alcohol Spectrum Disorder Treatment Market
The global Fetal Alcohol Spectrum Disorder Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Fetal Alcohol Spectrum Disorder Treatment Scope and Market Size
Fetal Alcohol Spectrum Disorder Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Fetal Alcohol Spectrum Disorder Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Forest Laboratories
Wyeth
Amneal Pharms
GlaxoSmithKline
Eli Lilly
Schering-Plough
Pfizer
…

Market segment by Type, the product can be split into
Antidepressants
Stimulants
Neuroleptics
Antianxiety Drugs
Market segment by Application, split into
Hospital Pharmacies
Retail Pharmacies
Drug Store
E-Commerce

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Fetal Alcohol Spectrum Disorder Treatment Revenue
1.4 Market by Type
1.4.1 Global Fetal Alcohol Spectrum Disorder Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Antidepressants
1.4.3 Stimulants
1.4.4 Neuroleptics
1.4.5 Antianxiety Drugs
1.5 Market by Application
1.5.1 Global Fetal Alcohol Spectrum Disorder Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Drug Store
1.5.5 E-Commerce
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Fetal Alcohol Spectrum Disorder Treatment Market Perspective (2015-2026)
2.2 Global Fetal Alcohol Spectrum Disorder Treatment Growth Trends by Regions
2.2.1 Fetal Alcohol Spectrum Disorder Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Fetal Alcohol Spectrum Disorder Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Fetal Alcohol Spectrum Disorder Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Fetal Alcohol Spectrum Disorder Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Fetal Alcohol Spectrum Disorder Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Fetal Alcohol Spectrum Disorder Treatment Players by Market Size
3.1.1 Global Top Fetal Alcohol Spectrum Disorder Treatment Players by Revenue (2015-2020)
3.1.2 Global Fetal Alcohol Spectrum Disorder Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Fetal Alcohol Spectrum Disorder Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Fetal Alcohol Spectrum Disorder Treatment Market Concentration Ratio
3.2.1 Global Fetal Alcohol Spectrum Disorder Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Fetal Alcohol Spectrum Disorder Treatment Revenue in 2019
3.3 Fetal Alcohol Spectrum Disorder Treatment Key Players Head office and Area Served
3.4 Key Players Fetal Alcohol Spectrum Disorder Treatment Product Solution and Service
3.5 Date of Enter into Fetal Alcohol Spectrum Disorder Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Fetal Alcohol Spectrum Disorder Treatment Historic Market Size by Type (2015-2020)
4.2 Global Fetal Alcohol Spectrum Disorder Treatment Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Fetal Alcohol Spectrum Disorder Treatment Market Size by Application (2015-2020)
5.2 Global Fetal Alcohol Spectrum Disorder Treatment Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Fetal Alcohol Spectrum Disorder Treatment Market Size (2015-2020)
6.2 Fetal Alcohol Spectrum Disorder Treatment Key Players in North America (2019-2020)
6.3 North America Fetal Alcohol Spectrum Disorder Treatment Market Size by Type (2015-2020)
6.4 North America Fetal Alcohol Spectrum Disorder Treatment Market Size by Application (2015-2020)

7 Europe
7.1 Europe Fetal Alcohol Spectrum Disorder Treatment Market Size (2015-2020)
7.2 Fetal Alcohol Spectrum Disorder Treatment Key Players in Europe (2019-2020)
7.3 Europe Fetal Alcohol Spectrum Disorder Treatment Market Size by Type (2015-2020)
7.4 Europe Fetal Alcohol Spectrum Disorder Treatment Market Size by Application (2015-2020)

8 China
8.1 China Fetal Alcohol Spectrum Disorder Treatment Market Size (2015-2020)
8.2 Fetal Alcohol Spectrum Disorder Treatment Key Players in China (2019-2020)
8.3 China Fetal Alcohol Spectrum Disorder Treatment Market Size by Type (2015-2020)
8.4 China Fetal Alcohol Spectrum Disorder Treatment Market Size by Application (2015-2020)

9 Japan
9.1 Japan Fetal Alcohol Spectrum Disorder Treatment Market Size (2015-2020)
9.2 Fetal Alcohol Spectrum Disorder Treatment Key Players in Japan (2019-2020)
9.3 Japan Fetal Alcohol Spectrum Disorder Treatment Market Size by Type (2015-2020)
9.4 Japan Fetal Alcohol Spectrum Disorder Treatment Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Fetal Alcohol Spectrum Disorder Treatment Market Size (2015-2020)
10.2 Fetal Alcohol Spectrum Disorder Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Fetal Alcohol Spectrum Disorder Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Fetal Alcohol Spectrum Disorder Treatment Market Size by Application (2015-2020)

11 India
11.1 India Fetal Alcohol Spectrum Disorder Treatment Market Size (2015-2020)
11.2 Fetal Alcohol Spectrum Disorder Treatment Key Players in India (2019-2020)
11.3 India Fetal Alcohol Spectrum Disorder Treatment Market Size by Type (2015-2020)
11.4 India Fetal Alcohol Spectrum Disorder Treatment Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Fetal Alcohol Spectrum Disorder Treatment Market Size (2015-2020)
12.2 Fetal Alcohol Spectrum Disorder Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Fetal Alcohol Spectrum Disorder Treatment Market Size by Type (2015-2020)
12.4 Central & South America Fetal Alcohol Spectrum Disorder Treatment Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Forest Laboratories
13.1.1 Forest Laboratories Company Details
13.1.2 Forest Laboratories Business Overview
13.1.3 Forest Laboratories Fetal Alcohol Spectrum Disorder Treatment Introduction
13.1.4 Forest Laboratories Revenue in Fetal Alcohol Spectrum Disorder Treatment Business (2015-2020))
13.1.5 Forest Laboratories Recent Development
13.2 Wyeth
13.2.1 Wyeth Company Details
13.2.2 Wyeth Business Overview
13.2.3 Wyeth Fetal Alcohol Spectrum Disorder Treatment Introduction
13.2.4 Wyeth Revenue in Fetal Alcohol Spectrum Disorder Treatment Business (2015-2020)
13.2.5 Wyeth Recent Development
13.3 Amneal Pharms
13.3.1 Amneal Pharms Company Details
13.3.2 Amneal Pharms Business Overview
13.3.3 Amneal Pharms Fetal Alcohol Spectrum Disorder Treatment Introduction
13.3.4 Amneal Pharms Revenue in Fetal Alcohol Spectrum Disorder Treatment Business (2015-2020)
13.3.5 Amneal Pharms Recent Development
13.4 GlaxoSmithKline
13.4.1 GlaxoSmithKline Company Details
13.4.2 GlaxoSmithKline Business Overview
13.4.3 GlaxoSmithKline Fetal Alcohol Spectrum Disorder Treatment Introduction
13.4.4 GlaxoSmithKline Revenue in Fetal Alcohol Spectrum Disorder Treatment Business (2015-2020)
13.4.5 GlaxoSmithKline Recent Development
13.5 Eli Lilly
13.5.1 Eli Lilly Company Details
13.5.2 Eli Lilly Business Overview
13.5.3 Eli Lilly Fetal Alcohol Spectrum Disorder Treatment Introduction
13.5.4 Eli Lilly Revenue in Fetal Alcohol Spectrum Disorder Treatment Business (2015-2020)
13.5.5 Eli Lilly Recent Development
13.6 Schering-Plough
13.6.1 Schering-Plough Company Details
13.6.2 Schering-Plough Business Overview
13.6.3 Schering-Plough Fetal Alcohol Spectrum Disorder Treatment Introduction
13.6.4 Schering-Plough Revenue in Fetal Alcohol Spectrum Disorder Treatment Business (2015-2020)
13.6.5 Schering-Plough Recent Development
13.7 Pfizer
13.7.1 Pfizer Company Details
13.7.2 Pfizer Business Overview
13.7.3 Pfizer Fetal Alcohol Spectrum Disorder Treatment Introduction
13.7.4 Pfizer Revenue in Fetal Alcohol Spectrum Disorder Treatment Business (2015-2020)
13.7.5 Pfizer Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Fetal Alcohol Spectrum Disorder Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Fetal Alcohol Spectrum Disorder Treatment Revenue
Table 3. Ranking of Global Top Fetal Alcohol Spectrum Disorder Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Fetal Alcohol Spectrum Disorder Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Antidepressants
Table 6. Key Players of Stimulants
Table 7. Key Players of Neuroleptics
Table 8. Key Players of Antianxiety Drugs
Table 9. Global Fetal Alcohol Spectrum Disorder Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Fetal Alcohol Spectrum Disorder Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Fetal Alcohol Spectrum Disorder Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Fetal Alcohol Spectrum Disorder Treatment Market Share by Regions (2015-2020)
Table 13. Global Fetal Alcohol Spectrum Disorder Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Fetal Alcohol Spectrum Disorder Treatment Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Fetal Alcohol Spectrum Disorder Treatment Market Growth Strategy
Table 19. Main Points Interviewed from Key Fetal Alcohol Spectrum Disorder Treatment Players
Table 20. Global Fetal Alcohol Spectrum Disorder Treatment Revenue by Players (2015-2020) (Million US$)
Table 21. Global Fetal Alcohol Spectrum Disorder Treatment Market Share by Players (2015-2020)
Table 22. Global Top Fetal Alcohol Spectrum Disorder Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Fetal Alcohol Spectrum Disorder Treatment as of 2019)
Table 23. Global Fetal Alcohol Spectrum Disorder Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Fetal Alcohol Spectrum Disorder Treatment Product Solution and Service
Table 26. Date of Enter into Fetal Alcohol Spectrum Disorder Treatment Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Fetal Alcohol Spectrum Disorder Treatment Market Size by Type (2015-2020) (Million US$)
Table 29. Global Fetal Alcohol Spectrum Disorder Treatment Market Size Share by Type (2015-2020)
Table 30. Global Fetal Alcohol Spectrum Disorder Treatment Revenue Market Share by Type (2021-2026)
Table 31. Global Fetal Alcohol Spectrum Disorder Treatment Market Size Share by Application (2015-2020)
Table 32. Global Fetal Alcohol Spectrum Disorder Treatment Market Size by Application (2015-2020) (Million US$)
Table 33. Global Fetal Alcohol Spectrum Disorder Treatment Market Size Share by Application (2021-2026)
Table 34. North America Key Players Fetal Alcohol Spectrum Disorder Treatment Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Fetal Alcohol Spectrum Disorder Treatment Market Share (2019-2020)
Table 36. North America Fetal Alcohol Spectrum Disorder Treatment Market Size by Type (2015-2020) (Million US$)
Table 37. North America Fetal Alcohol Spectrum Disorder Treatment Market Share by Type (2015-2020)
Table 38. North America Fetal Alcohol Spectrum Disorder Treatment Market Size by Application (2015-2020) (Million US$)
Table 39. North America Fetal Alcohol Spectrum Disorder Treatment Market Share by Application (2015-2020)
Table 40. Europe Key Players Fetal Alcohol Spectrum Disorder Treatment Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Fetal Alcohol Spectrum Disorder Treatment Market Share (2019-2020)
Table 42. Europe Fetal Alcohol Spectrum Disorder Treatment Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Fetal Alcohol Spectrum Disorder Treatment Market Share by Type (2015-2020)
Table 44. Europe Fetal Alcohol Spectrum Disorder Treatment Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Fetal Alcohol Spectrum Disorder Treatment Market Share by Application (2015-2020)
Table 46. China Key Players Fetal Alcohol Spectrum Disorder Treatment Revenue (2019-2020) (Million US$)
Table 47. China Key Players Fetal Alcohol Spectrum Disorder Treatment Market Share (2019-2020)
Table 48. China Fetal Alcohol Spectrum Disorder Treatment Market Size by Type (2015-2020) (Million US$)
Table 49. China Fetal Alcohol Spectrum Disorder Treatment Market Share by Type (2015-2020)
Table 50. China Fetal Alcohol Spectrum Disorder Treatment Market Size by Application (2015-2020) (Million US$)
Table 51. China Fetal Alcohol Spectrum Disorder Treatment Market Share by Application (2015-2020)
Table 52. Japan Key Players Fetal Alcohol Spectrum Disorder Treatment Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Fetal Alcohol Spectrum Disorder Treatment Market Share (2019-2020)
Table 54. Japan Fetal Alcohol Spectrum Disorder Treatment Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Fetal Alcohol Spectrum Disorder Treatment Market Share by Type (2015-2020)
Table 56. Japan Fetal Alcohol Spectrum Disorder Treatment Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Fetal Alcohol Spectrum Disorder Treatment Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Fetal Alcohol Spectrum Disorder Treatment Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Fetal Alcohol Spectrum Disorder Treatment Market Share (2019-2020)
Table 60. Southeast Asia Fetal Alcohol Spectrum Disorder Treatment Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Fetal Alcohol Spectrum Disorder Treatment Market Share by Type (2015-2020)
Table 62. Southeast Asia Fetal Alcohol Spectrum Disorder Treatment Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Fetal Alcohol Spectrum Disorder Treatment Market Share by Application (2015-2020)
Table 64. India Key Players Fetal Alcohol Spectrum Disorder Treatment Revenue (2019-2020) (Million US$)
Table 65. India Key Players Fetal Alcohol Spectrum Disorder Treatment Market Share (2019-2020)
Table 66. India Fetal Alcohol Spectrum Disorder Treatment Market Size by Type (2015-2020) (Million US$)
Table 67. India Fetal Alcohol Spectrum Disorder Treatment Market Share by Type (2015-2020)
Table 68. India Fetal Alcohol Spectrum Disorder Treatment Market Size by Application (2015-2020) (Million US$)
Table 69. India Fetal Alcohol Spectrum Disorder Treatment Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Fetal Alcohol Spectrum Disorder Treatment Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Fetal Alcohol Spectrum Disorder Treatment Market Share (2019-2020)
Table 72. Central & South America Fetal Alcohol Spectrum Disorder Treatment Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Fetal Alcohol Spectrum Disorder Treatment Market Share by Type (2015-2020)
Table 74. Central & South America Fetal Alcohol Spectrum Disorder Treatment Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Fetal Alcohol Spectrum Disorder Treatment Market Share by Application (2015-2020)
Table 76. Forest Laboratories Company Details
Table 77. Forest Laboratories Business Overview
Table 78. Forest Laboratories Product
Table 79. Forest Laboratories Revenue in Fetal Alcohol Spectrum Disorder Treatment Business (2015-2020) (Million US$)
Table 80. Forest Laboratories Recent Development
Table 81. Wyeth Company Details
Table 82. Wyeth Business Overview
Table 83. Wyeth Product
Table 84. Wyeth Revenue in Fetal Alcohol Spectrum Disorder Treatment Business (2015-2020) (Million US$)
Table 85. Wyeth Recent Development
Table 86. Amneal Pharms Company Details
Table 87. Amneal Pharms Business Overview
Table 88. Amneal Pharms Product
Table 89. Amneal Pharms Revenue in Fetal Alcohol Spectrum Disorder Treatment Business (2015-2020) (Million US$)
Table 90. Amneal Pharms Recent Development
Table 91. GlaxoSmithKline Company Details
Table 92. GlaxoSmithKline Business Overview
Table 93. GlaxoSmithKline Product
Table 94. GlaxoSmithKline Revenue in Fetal Alcohol Spectrum Disorder Treatment Business (2015-2020) (Million US$)
Table 95. GlaxoSmithKline Recent Development
Table 96. Eli Lilly Company Details
Table 97. Eli Lilly Business Overview
Table 98. Eli Lilly Product
Table 99. Eli Lilly Revenue in Fetal Alcohol Spectrum Disorder Treatment Business (2015-2020) (Million US$)
Table 100. Eli Lilly Recent Development
Table 101. Schering-Plough Company Details
Table 102. Schering-Plough Business Overview
Table 103. Schering-Plough Product
Table 104. Schering-Plough Revenue in Fetal Alcohol Spectrum Disorder Treatment Business (2015-2020) (Million US$)
Table 105. Schering-Plough Recent Development
Table 106. Pfizer Company Details
Table 107. Pfizer Business Overview
Table 108. Pfizer Product
Table 109. Pfizer Revenue in Fetal Alcohol Spectrum Disorder Treatment Business (2015-2020) (Million US$)
Table 110. Pfizer Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Fetal Alcohol Spectrum Disorder Treatment Market Share by Type: 2020 VS 2026
Figure 2. Antidepressants Features
Figure 3. Stimulants Features
Figure 4. Neuroleptics Features
Figure 5. Antianxiety Drugs Features
Figure 6. Global Fetal Alcohol Spectrum Disorder Treatment Market Share by Application: 2020 VS 2026
Figure 7. Hospital Pharmacies Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. Drug Store Case Studies
Figure 10. E-Commerce Case Studies
Figure 11. Fetal Alcohol Spectrum Disorder Treatment Report Years Considered
Figure 12. Global Fetal Alcohol Spectrum Disorder Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Fetal Alcohol Spectrum Disorder Treatment Market Share by Regions: 2020 VS 2026
Figure 14. Global Fetal Alcohol Spectrum Disorder Treatment Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Fetal Alcohol Spectrum Disorder Treatment Market Share by Players in 2019
Figure 17. Global Top Fetal Alcohol Spectrum Disorder Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Fetal Alcohol Spectrum Disorder Treatment as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Fetal Alcohol Spectrum Disorder Treatment Revenue in 2019
Figure 19. North America Fetal Alcohol Spectrum Disorder Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Fetal Alcohol Spectrum Disorder Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Fetal Alcohol Spectrum Disorder Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Fetal Alcohol Spectrum Disorder Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Fetal Alcohol Spectrum Disorder Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Fetal Alcohol Spectrum Disorder Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Fetal Alcohol Spectrum Disorder Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed

以下、関連資料のご紹介
  • 自閉症スペクトラム障害（ASD）治療の世界市場（～2026年）
    Global Autism Spectrum Disorder (ASD) Treatment Market Size, Status and Forecast 2020-2026
    MRC2-11QY10928 2020年11月25日 94Pages
    当調査資料は自閉症スペクトラム障害（ASD）治療のグローバル市場について調査・分析したレポートです。種類別（自閉症、アスペルガー症候群、広汎性発達障害、小児期崩壊性障害）市場規模、用途別（病院・クリニック、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア...
  • 脂質異常症治療の世界市場（～2026年）
    Global Lipid Disorder Treatment Market Size, Status and Forecast 2020-2026
    MRC2-11QY12520 2020年11月25日 92Pages
    当調査資料は脂質異常症治療のグローバル市場について調査・分析したレポートです。種類別（アトルバスタチン、フルバスタチン、ロスバスタチン、シンバスタチン、プラバスタチン、その他薬剤）市場規模、用途別（病院、クリニック、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス...
  • 甲状腺障害治療の世界市場（～2026年）
    Global Thyroid Gland Disorder Treatment Market Size, Status and Forecast 2020-2026
    MRC2-11QY04853 2020年11月20日 93Pages
    当調査資料は甲状腺障害治療のグローバル市場について調査・分析したレポートです。種類別（甲状腺機能亢進症、甲状腺機能低下症、その他）市場規模、用途別（男性、女性）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラ...
  • ENT疾患治療の世界市場（～2026年）
    Global ENT Disorder Treatment Market Size, Status and Forecast 2020-2026
    MRC2-11QY11841 2020年11月25日 92Pages
    当調査資料はENT疾患治療のグローバル市場について調査・分析したレポートです。種類別（扁桃炎、耳感染症、副鼻腔感染症、睡眠時無呼吸）市場規模、用途別（病院、クリニック、外来手術センター、在宅介護施設、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシ...
  • 季節性情動障害治療の世界市場（～2026年）
    Global Seasonal Affective Disorder Treatment Market Size, Status and Forecast 2020-2026
    MRC2-11QY04565 2020年11月20日 90Pages
    当調査資料は季節性情動障害治療のグローバル市場について調査・分析したレポートです。種類別（光線療法（光線療法）、薬物、心理療法、カウンセリング、その他）市場規模、用途別（病院、診療所、医学研究センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロ...
  • 認知症・運動障害治療の世界市場（～2026年）
    Global Dementia and Movement Disorder Treatment Market Size, Status and Forecast 2020-2026
    MRC2-11QY11592 2020年11月25日 94Pages
    当調査資料は認知症・運動障害治療のグローバル市場について調査・分析したレポートです。種類別（MAO阻害剤（モノアミン酸化酵素）、AChE阻害剤（アセチルコリンエステラーゼ）、グルタミン酸阻害剤）市場規模、用途別（ブランド薬品、ジェネリック薬品）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ...
  • 強迫性障害治療の世界市場（～2026年）
    Global Obsessive-Compulsive Disorder Treatment Market Size, Status and Forecast 2020-2026
    MRC2-11QY04031 2020年11月20日 90Pages
    当調査資料は強迫性障害治療のグローバル市場について調査・分析したレポートです。種類別（ADX-88178、ビトペルチン、CR-5542、ジプラグラントIR、マレイン酸フルボキサミン、マボグルラント、その他）市場規模、用途別（クリニック、病院、研究センター）市場規模、地域別（北米、米国、カナダ、ヨーロ...
  • 慢性うつ病性人格障害治療の世界市場（～2026年）
    Global Chronic Depressive Personality Disorder Treatment Market Size, Status and Forecast 2020-2026
    MRC2-11QY11360 2020年11月25日 96Pages
    当調査資料は慢性うつ病性人格障害治療のグローバル市場について調査・分析したレポートです。種類別（選択的セロトニン再取り込み阻害薬、三環系抗うつ薬、ノルエピネフリン再取り込み阻害薬、その他）市場規模、用途別（病院薬局、小売薬局、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、...
  • 多形性膠芽腫（GBM）治療の世界市場（～2026年）
    Global Glioblastoma Multiforme Treatment (GBM) Market Size, Status and Forecast 2020-2026
    MRC2-11QY12056 2020年11月25日 92Pages
    当調査資料は多形性膠芽腫（GBM）治療のグローバル市場について調査・分析したレポートです。種類別（化学療法、放射線療法、遺伝子治療、分子バイオテクノロジー）市場規模、用途別（ベバコズマブ、カルムスチン、テモゾロミド）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリ...
  • 神経精神障害・治療の世界市場（～2026年）
    Global Neuropsychiatric Disorders And Treatment Market Size, Status and Forecast 2020-2026
    MRC2-11QY03957 2020年11月20日 97Pages
    当調査資料は神経精神障害・治療のグローバル市場について調査・分析したレポートです。種類別（変性疾患、神経症、精神病）市場規模、用途別（病院、診療所、研究センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オースト...
  • 自閉症スペクトラム障害（ASD）治療の世界市場（～2026年）自閉症スペクトラム障害（ASD）治療の世界市場（～2026年） Autism spectrum disorder (ASD) refers to a group of complex neurodevelopment disorders characterized by repetitive and characteristic patterns of behavior and difficulties with social communication and interaction. According to CDC statistics, 1 in every 68 children suffers with autism. Innovative d…
  • 脂質異常症治療の世界市場（～2026年）脂質異常症治療の世界市場（～2026年） Lipid disorder means the people high blood levels of low-density lipoprotein (LDL) cholesterol, fats called triglycerides,. Several biopharma companies are focusing on developing effective solutions for treating lipid disorders. Companies involved in lipid disorder treatment market include Teva Phar…
  • 甲状腺障害治療の世界市場（～2026年）甲状腺障害治療の世界市場（～2026年） Hormones released by thyroid gland play a crucial role in stimulating metabolism, growth, and calories processing. Globally, thyroid gland disorders such as hypothyroidism, hyperthyroidism, and thyroid nodules affect around 5% to 10% of the population. Hyperthyroidism and hypothyroidism affect major…
  • 慢性うつ病性人格障害治療の世界市場（～2026年）慢性うつ病性人格障害治療の世界市場（～2026年） Chronic depressive personality disorder also known as Dysthymia is a chronic form of depression. It is mild form of depression which last up to two years or more. This disorder is less severe in comparison to other forms of depression. Symptoms of chronic depressive personality disorder are loss of …
  • ENT疾患治療の世界市場（～2026年）ENT疾患治療の世界市場（～2026年） ENT is a medical abbreviation for ears, nose and throat. Major factor contributing to growth of the global ENT disorder treatment market includes increasing pollution. Market Analysis and Insights: Global ENT Disorder Treatment Market The global ENT Disorder Treatment market size is projected to rea…